Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3035)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 15, 2022 (publication date) through Jun 7, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin JR, Wang ZT, Sun JJ, Yang YY, Li XX, Wang XR, Shi Y, Zhu YY, Wang RT, Wang MN, Xie FY, Wei P, Liao ZH. Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives. World J Diabetes 2022; 13(4): 308-318 [PMID: 35582668 DOI: 10.4239/wjd.v13.i4.308] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/308.htm |
| Number | Citing Articles |
| 1 |
Jiajia Wu, Yan Chen, Huinan Yang, Leyi Gu, Zhaohui Ni, Shan Mou, Jianxiao Shen, Xiajing Che. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1026040
|
| 2 |
Soumik Das, Ramanathan Gnanasambandan. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective. Life Sciences 2023; 316: 121414 doi: 10.1016/j.lfs.2023.121414
|
| 3 |
Shisheng Han, Min Chen, Pei Cheng, Zeng Zhang, Yan Lu, Yanqiu Xu, Yi Wang. A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1018093
|
| 4 |
Lavinia Balint, Carmen Socaciu, Andreea Iulia Socaciu, Adrian Vlad, Florica Gadalean, Flaviu Bob, Oana Milas, Octavian Marius Cretu, Anca Suteanu-Simulescu, Mihaela Glavan, Silvia Ienciu, Maria Mogos, Dragos Catalin Jianu, Ligia Petrica. Metabolite Profiling of the Gut–Renal–Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients. International Journal of Molecular Sciences 2023; 24(7): 6212 doi: 10.3390/ijms24076212
|
| 5 |
Xiaofang Wu, Lei Zhao, Yujiang Zhang, Kailong Li, Jurong Yang. The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1166685
|
| 6 |
Shruti Bhargava, Erik Merckelbach, Heidi Noels, Ashima Vohra, Joachim Jankowski. Homeostasis in the Gut Microbiota in Chronic Kidney Disease. Toxins 2022; 14(10): 648 doi: 10.3390/toxins14100648
|